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LETTERS
Rapid collaboration between pub-
lic health authorities in the Philippines 
and Finland led to appropriate action 
at the site of origin of the rabies case 
within a few days. In a country in 
which rabies is not endemic, diagnos-
ing rabies and implementing control 
measures in healthcare settings are of-
ten difﬁ  cult because of limited experi-
ence with this disease. The last human 
rabies case in Finland was diagnosed 
in 1985, when a bat researcher died 
after being bitten by bats abroad and 
in Finland (5). For imported cases, pa-
tient history may be incomplete, but 
use of RT-PCR for saliva can provide a 
rapid conﬁ  rmation of the diagnosis. To 
support risk assessment and decision 
making, better deﬁ  nition of the roles 
of public health authorities regarding 
a mandate or responsibility to acquire 
information concerning international 
ships is needed.
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Eye-Opening 
Approach to 
Norovirus 
Surveillance
To the Editor: It is said that a 
picture is worth a thousand words. 
The Figure illustrates this axiom and 
provides several new insights into the 
spread of norovirus infections. These 
infections are assumed to greatly af-
fect society, but little is known about 
the prevalence of the disease in the 
community. Samples sent to labora-
tories usually originate from hospital-
ized persons and thus give a good view 
of the situation in healthcare settings. 
We suspect, however, that these num-
bers do not depict the true prevalence 
of norovirus  infections in society. 
We therefore present a new approach 
to estimate the number of cases and 
spread of norovirus infections in the 
community.
We plotted the number of queries 
for *vomit* (asterisks denote any pre-
ﬁ  x or sufﬁ  x) submitted to the search 
engine on a medical website in Swe-
den (www.vardguiden.se). This num-
ber was normalized to account for 
the increasing use of the website over 
time and aggregated by week, starting 
with week 40 in 2005. We also plotted 
the number of norovirus ﬁ  ndings per 
week from 16 regional laboratories, as 
recorded by the Swedish Institute for 
Infectious Disease Control.
For the time series on Web search 
queries and laboratory ﬁ  ndings (Fig-
ure), we ﬁ  tted harmonic functions on 
the half-year with no or little activ-
ity, deﬁ  ning baselines for each series 
(1,2). By performing this procedure, 
we can identify the onset of each ac-
tivity that is assumed to occur when 
the level rises above the 99% predic-
tion interval of the baseline. The week 
this increase occurs is shown in the 
Figure. The Figure also contains the 
number of media articles on winter 
vomiting disease  provided by a search 
engine for news in Sweden (www.
eniro.se/nyhetssok). By analyzing the 
ﬁ  gure and investigating the statistical 
outcomes, we glimpse the prevalence 
of norovirus infections in society, as 
estimated by the search pattern.
We found 3 striking insights. 
First, the onset of vomiting in the 
community precedes the onset of 
conﬁ   rmed norovirus infections in 
healthcare settings. In 3 of the 4 full 
seasons investigated, this precedence 
was 1–4 weeks. Second, the curve for 
the Web queries shows much sharper 
increases and decreases than does the 
curve on the number of reported no-
rovirus ﬁ  ndings. Third, neither search 
behavior nor reporting of positive 
tests is driven by media for the winter 
vomiting disease (conﬁ  rmed by a lin-
ear regression).
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In the 2005–06 season, the labo-
ratory reporting raised above the de-
ﬁ  ned prediction interval in week 13, 
much later than the Web queries. This 
season had no new variants of no-
rovirus genotype GII.4. This season 
still showed community infections, 
even though few reports came from 
institutions. For the current season 
(2009–10), the interval between on-
set of Web queries and onset of no-
rovirus infections in hospitals (week 
46 and week 1, respectively) was 8 
weeks. In comparison with previous 
seasons, this delay could mean a low 
total number of reported cases. How-
ever, in late December, a new variant 
of GII.4 affected healthcare settings 
in southern Sweden with increasing 
norovirus infections, while the rest 
of the country still showed relatively 
low virus activity.
Other pathogens such as rotavi-
rus,  Salmonella  spp.,  Staphylococcus 
aureus, and Bacillus cereus can cause 
vomiting. Usually in Sweden, rotavirus 
infections peak in late winter, and bac-
terial diseases have a minor incidence 
compared with norovirus. In our opin-
ion, these other pathogens would not 
interfere with the interpretation of the 
results.
In our routine surveillance of 
Web queries, we also include other 
query terms, such as diarrhea and 
stomach  ﬂ  u. However, searches for 
vomiting show the most distinct pat-
tern, and vomiting is the most pro-
nounced symptom of a norovirus 
infection.
The use of harmonic functions for 
describing baseline Web searches and 
laboratory reporting is a simple model, 
especially because the parameters are 
estimated by using the half-year with 
the least activity. Nonetheless, it is a 
direct approach, and we believe that 
the method still captures the time of 
onsets well.
Web queries indicate the presence 
of norovirus infections in communi-
ties. Predictions of the onset of the 
norovirus laboratory reporting should 
also be possible, but further studies 
are needed to conﬁ  rm that theory. Web 
queries have previously been correlat-
ed with inﬂ  uenza (3–7) and have been 
explored retrospectively for listeriosis 
(8),  Salmonella spp. (9), West Nile 
virus, and respiratory syncytial virus 
(10). With the Web queries, we get an 
additional surveillance system for the 
time of the year when few norovirus 
tests are conducted. In addition, know-
ing more about the impact of norovi-
rus in the community means that we 
could provide more adequate informa-
tion and advocate wiser measures for 
prevention and control.
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Figure. Number of queries for *vomit* submitted to a medical Web site (A), number of 
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Possible Recurrent 
Pandemic (H1N1) 
2009 Infection, 
Israel
To the Editor: We report 2 cas-
es of possible recurrent laboratory-
conﬁ   rmed infection with pandemic 
(H1N1) 2009 virus in Israel. Patient 
1, a 24-year-old man, had Noonan 
syndrome (1,2). He was hospitalized 
on August 10, 2009, because of high-
grade fever and cough. At admission, a 
nasopharyngeal specimen was collect-
ed for pandemic (H1N1) 2009 virus 
real-time reverse transcription–PCR 
(RT-PCR) (ABI 7500; Applied Bio-
systems, Foster City, CA, USA) for 
the pandemic hemagglutinin gene; a 
validated in-house protocol developed 
at Israel Central Virology Laboratory 
was used, as previously described (3). 
Brieﬂ  y, the in-house assay was vali-
dated against the assay for pandemic 
(H1N1) 2009 virus developed by the 
Centers for Disease Control and Pre-
vention (CDC; Atlanta, GA, USA). 
The in-house assay was as sensitive as 
the CDC assay; however, the in-house 
primers and probes were more speciﬁ  c 
for detecting pandemic (H1N1) 2009 
virus with 105% ampliﬁ  cation  efﬁ  -
ciency of viral RNA that was logarith-
mically serially diluted. In addition, of 
100 samples tested side by side with 
the in-house and CDC assays, 75 sam-
ples were positive by both assays, and 
25 were negative by both assays; thus, 
the sensitivity and speciﬁ  city of the in-
house assay were 100%.
The patient was not treated with 
neuraminidase inhibitors and did not 
require supportive treatment; after 
1 day of hospitalization, he was dis-
charged with a diagnosis of upper 
respiratory tract infection. The labo-
ratory subsequently reported the RT-
PCR as positive for pandemic (H1N1) 
2009 virus. On November 22, the man 
was hospitalized again for dyspnea 
and fever. The RT-PCR result from a 
nasopharyngeal sample collected at 
admission was positive. Hemaggluti-
nation-inhibition assay demonstrated 
a high titer (320) of serum antibody 
against pandemic (H1N1) 2009 virus 
in a blood sample taken at admission. 
The patient took oseltamivir for 5 
days, and his condition markedly im-
proved. Result of a repeat RT-PCR at 
discharge was negative.
An identical neuraminidase gene 
sequence was detected during both 
illness episodes (August and Novem-
ber). The specimens were also tested 
with an experimental RT-PCR assay 
for rapid detection of the oseltamivir 
resistance mutation H275Y on the 
pandemic neuraminidase gene (4). 
For specimens collected during both 
episodes, the virus was oseltamivir 
sensitive. 
Patient 2, a 13.5-year-old boy, 
had severe cerebral palsy. On July 
27, 2009, high-grade fever with dys-
pnea developed. He was treated as an 
outpatient for 5 days with oseltamivir 
and clinically improved. However, on 
August 11, he had fever with respira-
tory distress and was hospitalized. RT-
PCR for pandemic (H1N1) 2009 virus 
was positive on August 14.  A second 
course of oseltamivir was administered 
for 10 days with the dosage adjusted 
for age and doubled from that of the 
previous regimen. Further testing with 
the experimental rapid RT-PCR indi-
cated the viral strain had the oseltami-
vir resistance mutation. On September 
14, RT-PCR was negative. 
On December 11, the boy was 
again hospitalized because of respi-
ratory distress and high-grade fever. 
On December 14, RT-PCR was posi-
tive for pandemic (H1N1) 2009 virus, 
and a 5-day regimen of oseltamivir 
was started. Another specimen taken 
the same day was negative. A high se-
rum antibody titer (320) to pandemic 
(H1N1) 2009 virus was measured by 
hemagglutination-inhibition assay on 
December 16; no oseltamivir resis-
tance mutation was found. Additional 
laboratory testing included a complete 
panel for respiratory viruses, which 
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